Achieve Life Sciences Announces Presentation at 2023 American Society of Pharmacognosy Annual Meeting
July 18, 2023 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, July 18, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage pharmaceutical company committed to the global development and...
Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA)
July 11, 2023 11:23 ET
|
Achieve Life Sciences
Cytisinicline 6- and 12-week dosing schedules, with behavioral support, demonstrated “smoking cessation efficacy and excellent tolerability” Supports potential for cytisinicline to be the first...
Growth Report: Digital Therapeutics Market Worth $18 Billion, Globally, by 2028 at 23.1% CAGR | The Insight Partners
June 21, 2023 10:26 ET
|
The Insight Partners
Pune, India, June 21, 2023 (GLOBE NEWSWIRE) -- According to our latest study on "Digital Therapeutics Market Size Report, Forecast to 2028 – COVID-19 Impact and Global Analysis – by Application, and...
New solutions urgently needed to tackle smoking worldwide: experts to convene in Poland at the Global Forum on Nicotine
June 19, 2023 10:17 ET
|
Global Forum on Nicotine
WARSAW, Poland, June 19, 2023 (GLOBE NEWSWIRE) -- International public health specialists, scientists, doctors, regulators, consumers and manufacturers are convening this week in the Polish capital...
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
June 06, 2023 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, June 06, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Achieve Life Sciences Announces Pricing of $16.5 Million Registered Direct Offering
May 25, 2023 09:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 25, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Achieve Life Sciences Reports Statistically Significant Smoking Cessation Benefit for Cytisinicline in Second, Confirmatory Phase 3 Clinical Trial
May 23, 2023 06:00 ET
|
Achieve Life Sciences
ORCA-3 demonstrated statistically significant topline results in primary and secondary smoking cessation endpoints for both 6- and 12-week cytisinicline treatment durations compared to placebo ...
Achieve Life Sciences Announces Refinancing of Outstanding Loan with Silicon Valley Bank
May 17, 2023 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 17, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Achieve Life Sciences Reports Financial Results for First Quarter 2023 and Provides Corporate Update
May 09, 2023 16:05 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 09, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Achieve Life Sciences to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 9, 2023
April 26, 2023 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, April 26, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...